Back to Trials
NCT07239219NARecruitingAccepts Healthy Volunteers

The Impact of Irrisept in Reducing Urinary Tract Infection During Urethral Catheter Removal.

Ohio State University

Start Date

1/1/2026

Completion Date

1/1/2028

Summary

Given the high burden of post-catheter removal UTIs, this study aims to evaluate Irrisept instillation as a non-antibiotic intervention to reduce infection rates. By comparing Irrisept to saline irrigation, the study will provide critical insights into the efficacy of antiseptic bladder irrigation in preventing UTIs while minimizing antibiotic use. If successful, this approach could lead to new clinical guidelines for catheter removal protocols, improving patient outcomes and reducing healthcare costs.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: 1. Presenting to the urology clinic for catheter removal 2. Must be 18 years or older. 3. The patient must be able to understand and willing to provide informed consent as described in this study protocol. 4. Must be willing to complete a post-catheter removal survey Exclusion Criteria: 1. Allergy or adverse reaction to chlorohexidine gluconate 2. Under the age of 18 3. Refuse to provide informed consent 4. On antibiotic therapy for any indication. 5. Women who are pregnant or breastfeeding 6. Signs of skin or systemic infection 7. Patients undergoing catheter exchange

Interventions

OTHER

0.05% Chlorhexidine Gluconate

OTHER

Normal Saline

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Urinary Tract InfectionAntibioticCatheter Infection

Locations

The Ohio State University

Columbus, Ohio 43212-3153

United States